Dark

Check out our API

KPRX
Kiora Pharmaceuticals, Inc. Common Stock
stock NASDAQ

Market Open

Jul 24, 2026 9:37:15 AM EDT

2.33USD-6.800%(-0.17)126,112

2.38Bid 2.93Ask 0.55Spread

Pre-market

0.00USD-100.000%(-2.50)0

After-hours

Jul 23, 2026 4:00:30 PM EDT

2.50USD-0.200%(-0.01)0

OverviewHistoricalExchangesShortsNews

Jan 19, 2022

10:02AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022 Benzinga

08:20AM EST Maxim Group Initiates Coverage On Kiora Pharmaceuticals with Buy Rating, Announces Price Target of $2.5 Benzinga

Jan 5, 2022

07:08AM EST Kiora Pharmaceuticals to Provide 2022 Business Outlook at the H.C. Wainwright Bioconnect Virtual Conference Benzinga

Dec 30, 2021

02:38PM EST Mid-Afternoon Market Update: Nasdaq Rises 70 Points; Future FinTech Shares Spike Higher Benzinga

Nov 15, 2021

10:58AM EST Kiora Pharmaceuticals Reports Cash And Equivalents Of $11.107M As Of Sept. 30 Benzinga

07:30AM EST Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), (Kiora or the Company) today reported its financial results for the quarter ended September 30, 2021 and provided an update on recent corporate and operational activities. GlobeNewswire Inc

Share